客户发表文献

论文在线提交

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

开始时间
页码: 216/4751 每页显示数量
Inhibitor of DNA binding 2 (ID2) regulates the expression of developmental genes and tumorigenesis in ewing sarcoma
Authors: Stacia L Koppenhafer, Kelli L Goss, Ellen Voigt, Emma Croushore, William W Terry, Jason Ostergaard, Peter M Gordon, David J Gordon
Journal: Oncogene
PubMed ID: 35422476
Doi: 10.1038/s41388-022-02310-0
Products & Services: Plasmid DNA Preparation   
Immunization With Recombinant Y75B8A8 Partially Protects Local Crossbred Female Goats From Infection
Authors: Xiaowei Tian, Mingmin Lu, Yongqian Bu, Yang Zhang, Kalibixiati Aimulajiang, Meng Liang, Charles Li, Ruofeng Yan, Lixin Xu, Xiaokai Song, Xiangrui Li
Journal: Front Vet Sci
PubMed ID: 35445096
Doi: 10.3389/fvets.2022.765700
The miR-532-E2F1 feedback loop contributes to gastric cancer progression
Authors: Shanting Gao, Xiaomin Bu, Yongyue Gao, Zengtao Bao, Wenchao Shi, Lipeng Luan, Huiyu Chen, Baoming Zhang, Qingshui Tian, Wenxian Guan, Liuqing Yang
Journal: Cell Death Dis
PubMed ID: 35440106
Doi: 10.1038/s41419-022-04832-7
Products & Services: Plasmid DNA Preparation   
is a 3D matrix-specific mediator of mechanosensitive stem cell lineage commitment
Authors: Jieung Baek, Paola A Lopez, Sangmin Lee, Taek-Soo Kim, Sanjay Kumar, David V Schaffer
Journal: Sci Adv
PubMed ID: 35427160
Doi: 10.1126/sciadv.abm4646
Products & Services: Catalog Peptides   
Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosis
Authors: Yiqi Yang , Yixuan Lin , Minqi Wang , Kai Yuan , Qishan Wang , Pei Mu , Jingke Du , Zhifeng Yu , Shengbing Yang , Kai Huang , Yugang Wang , Hanjun Li , Tingting Tang
Journal: Bone Res
PubMed ID: 35260560
Doi: doi.org/10.1038/s41413-022-00198-w
DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas
Authors: Xizhou Zhu, Alfredo Perales-Puchalt, Krzysztof Wojtak, Ziyang Xu, Kun Yun, Pratik S Bhojnagarwala , Devivasha Bordoloi , Daniel H Park, Kevin Liaw, Mamadou A Bah, Paul M Lieberman , Ebony N Gary , Ami Patel , David B Weiner
Journal: Mol Ther Oncolytics
PubMed ID: 35071745
Doi: 10.1016/j.omto.2021.12.017
Products & Services: Plasmid DNA Preparation   Peptide Synthesis   
RNF115 Inhibits the Post-ER Trafficking ofTLRs and TLRs-Mediated Immune Responses by Catalyzing K11-Linked Ubiquitination ofRAB1A and RAB13
Authors: Zhi-Dong Zhang , Hong-Xu Li , Hu Gan , Zhen Tang , Yu-Yao Guo , Shu-Qi Yao , Tianzi Liuyu , Bo Zhong , Dandan Lin
Journal: Adv Sci (Weinh)
PubMed ID: 35343654
Doi: doi.org/10.1002/advs.202105391
Products & Services: Peptide Synthesis   
SARS-CoV-2 variant B.1.1.7 caused HLA-A2 CD8 T cell epitope mutations for impaired cellular immune response.
Authors: Chanchan Xiao, Lipeng Mao , Zhigang Wang , Lijuan Gao , Guodong Zhu , Jun Su , Xiongfei Chen , Jun Yuan , Yutian Hu, Zhinan Yin, Jun Xie , Weiqing Ji , Haitao Niu , Feng Gao, Oscar Junhong Luo , Lianbo Xiao , Pengcheng Wang , Guobing Chen
Journal: iScience
PubMed ID: 35194575
Doi: 10.1016/j.isci.2022.103934
Products & Services: Peptide Synthesis   
TFPIisacoloniccryptreceptorforTcdBfromhypervirulentclade2C.difficile
Authors: Jianhua Luo , Qi Yang , Xiaofeng Zhang , Yuanyuan Zhang , Li Wan , Xiechao Zhan , Yao Zhou , Liuqing He , Danyang Li , Dazhi Jin , Ying Zhen , Jing Huang , Yanyan Li , Liang Tao
Journal: Cell
PubMed ID: 35303428
Doi: 10.1016/j.cell.2022.02.010
Products & Services: Codon Optimization   
Small molecule targeting CELF1 RNA-binding activity to control HSC activation and liver fibrosis
Authors: Yang Tan, Xueqing Sun, Yizhu Xu, Bingjie Tang, Shuaiqi Xu, Dong Lu, Yan Ye, Xiaomin Luo, Xu Diao, Fulong Li, Tianyi Wang, Jiayu Chen, Qiang Xu, Xingxin Wu
Journal: Nucleic Acids Res
PubMed ID: 35234905
Doi: 10.1093/nar/gkac139
Products & Services: DNA Sequencing   
< 211 212 213 214 215 216 217 218 219 220 221 > Total Pages 4751

喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*